Clinical Study on the Efficiency of Rapid Arrhythmia Mapping Using EasyStars™ High Density Mapping Catheter Applications

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorShanghai MicroPort EP MedTech Co., Ltd.

About this trial

The primary objective of this study was to evaluate the clinical feasibility, safety, and surgical characteristics of the EasyStars™ High Density Mapping Catheterin in patients with complex arrhythmias.

Eligibility criteria

Qualifiers

Clinical diagnosis: Ventricular tachycardia (VT)

Patients aged between 18 and 80 years;

Confirmed diagnosis of ventricular tachycardia (VT) via electrocardiogram (ECG) or 24-hour Holter monitoring;

The patient has experienced at least one episode of VT in the past 6 months and exhibits symptoms of sustained or paroxysmal ventricular tachycardia;

Disqualifiers

Uncontrolled heart failure (New York Heart Association functional class III-IV);

History of acute or progressive myocardial infarction;

Severe pulmonary, hepatic, or renal disease;

Valvular heart disease or congenital heart disease;

Trial design

Treatments tested in this trial

  • EasyStars™ High Density Mapping Catheter

Treatment groups

300 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Shanghai MicroPort EP MedTech Co., Ltd.

Lead sponsor

Shanghai General Hospital, China

Collaborator